Ursa 100 mg (Ursodeoxycholic Acid)

Adult dose

As ursodeoxycholic acid, take 50-100mg at a time, 3 times a day.

This medication should not be taken by individuals allergic to certain ingredients. In cases of severe biliary obstruction, this medication may worsen symptoms, so it should be avoided. Acute hepatitis patients or patients with radiolucent calcified gallstones should also not take this medication. It is contraindicated for patients without gallbladder function or with acute cholecystitis, pregnant women or those who may become pregnant, nursing mothers, and children. Patients with kidney disease or inflammatory bowel diseases such as peptic ulcer or Crohn's disease should use this medication with caution. Additionally, patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. While taking this medication, it should not be taken with oral hypoglycemic agents, certain lipid-lowering medications, specific antacids, or activated charcoal. Combining with medications that can cause liver damage should also be avoided. In cases of severe pancreatic diseases or gallstones in the bile duct, and in patients with serious liver diseases such as esophageal variceal bleeding or hepatic coma, it is essential to consult a specialist before taking this medication. If symptoms such as diarrhea, nausea, vomiting, abdominal pain, itching, rash, etc. occur during use, discontinue use immediately and consult a specialist. Discontinue use immediately and consult medical personnel if symptoms of interstitial pneumonia appear. Regular liver function tests are important during treatment, and elderly patients may require dosage adjustments due to decreased physical function. When treating cholelithiasis, it is necessary to check the treatment progress through ultrasound or X-ray examinations every six months, and if there is no effect after 12 months, the treatment should be discontinued. This medication should be kept out of reach of children and stored sealed in its original container for safety.

Serious side effects

Fever, cough, shortness of breath, interstitial pneumonia accompanied by abnormalities on chest X-ray

Mild side effects

Diarrhea, nausea, vomiting, abdominal pain, constipation, heartburn, discomfort in the stomach, itching, rash, general malaise, dizziness, calcification of gallstones, increased liver enzyme levels (ALT, ALP, AST, γ-GT), leukopenia

Drug interactions

This medication may interact with oral hypoglycemic agents (tolbutamide), cholestyramine, colestipol, activated charcoal, magnesium, and antacids containing aluminum hydroxide. It should not be taken with medications that increase cholesterol secretion in the liver (oral contraceptives containing estrogen, lipid-lowering medications such as clofibrate) and with medications that can cause liver damage.

This medication should be kept in a sealed container to protect it from air and moisture, and it is best stored at room temperature that is not too hot or too cold. Storing it this way helps maintain the effect of the medication for a long time.

Appearance

White round tablet

Package unit

Bottle - 10 tablets/bottle, Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, Bottle - 300 tablets/bottle, Bottle - 500 tablets/bottle, PTP - 10 tablets/PTP, PTP - 100 tablets/PTP [(10 tablets/PTP) X10]